Many participants in phase 2 trials of MDMA-assisted psychotherapy for PTSD responded well to the treatment. But for some, PTSD symptoms are still present after MDMA and integration sessions. Can we predict who will respond?
Author: Alli Feduccia, PhD
Dr. Alli Feduccia is a Co-Founder and Director of Psychedelic.Support and Project New Day. She is a neuropharmacologist interested in advancing psychedelic research, medicinal use of psychedelics, and ceremonial practices that incorporate plant medicines.
Are Psychedelics Legal Now? Initiatives for Legalization and Decriminalization
Understanding the difference between legalization and decriminalization, and the implications of each, is critically important for voters, the psychedelic community, and health providers.
Five Things to Know Before Enrolling in a Psilocybin Clinical Trial
Are you interested in joining a clinical research trial for psilocybin? Here are five things to know about what to expect and how to get involved in psilocybin research studies.
Microdosing: Myth, Magic, or a Molecular Mechanism?
Microdosing is hailed as an all-inclusive approach to your physical and psychological issues. But is it real?
Enduring Benefits after MDMA-assisted Psychotherapy for PTSD Treatment
Post-traumatic stress disorder symptom improvement lasting years after MDMA-assisted psychotherapy. Principal Investigator Dr. Michael Mithoefer talks about the treatment approach and factors influencing the treatment response.
How To Join a Psychedelic Clinical Trial
You could be eligible to participate in a psychedelic research trial. We’ve compiled a list here of all the current or planned clinical trials on MDMA, psilocybin, LSD, ibogaine, and more.
How to Find the Best Psychedelic Integration Therapist for You
Finding the best fit therapist for you can be a daunting task, whether or not the work involves psychedelics. In this article, we share insights into finding the best therapist for you - navigating the degrees of health professionals, reflecting on your own needs, listing questions to ask when interviewing a therapist, and more.
FDA and NIH Perspectives on Psychedelic Drug Development
The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) communicated publicly about psychedelic drug development and current thinking around safety, therapeutic use, and research. The FDA Division of Psychiatry Products provided information in a workshop about how to design and efficiently study psychedelics for potential medical use.
MDMA Breakthrough Therapy Designation Results Published
Six phase 2 trials investigated MDMA-assisted psychotherapy for treatment of PTSD. Results that led to Breakthrough Therapy designation are now published.
How to Become a Psychedelic Therapist
Until recently, the only opportunity to train and work legally as a psychedelic therapist was in clinical trials. That will likely change over time as expanded access becomes the next step for current trials (evaluating MDMA and psilocybin) and if psychedelic-assisted therapies become FDA approved.
Can We Quantify the Placebo Effect in Psychedelic Medicine?
Here, take these pills. It will make you better. Likely you’ve heard these phrases before if you’re living in a medicalized society. For whatever ails you, there is a pill or an entire arsenal of medications that your doctor may prescribe. Some of these drugs are life-saving remedies with biological targets that interrupt disease progression
Healing Trauma with MDMA: A New Study Published
Patchwork Art from MAPS Therapist Training Program 2017Photo Credit: Alyssa Gursky Findings from the last study in a series of six Phase 2 trials of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder (PTSD) was published today in the Journal of Psychopharmacology [1]. The clinical trial in Boulder, Colorado (MP-12) enrolled 28 participants suffering from
First Clinical Trial: Social Anxiety in Autistic Adults Successfully Treated with MDMA Therapy
The first clinical trial in adults on the autism spectrum investigating MDMA, or any psychedelic substance for that matter, was published in Psychopharmacology this week [1]. This groundbreaking research looked at whether MDMA combined with psychotherapy could help with the severe social anxiety that autistic adults commonly experience. The drug-therapy combo wasn’t intended to be
